In 2015, SeqCenter’s founding team worked together within the walls of an academic lab at the University of Pittsburgh and began sequencing their own samples after consistently being frustrated with the pace, cost, and difficulty of obtaining sequencing data from existing vendors. After perfecting methodologies to allow for the economical sequencing of microbes, they offered the services to colleagues and collaborators. The quickly growing interest from peers indicated they had developed a viable commodity; however, policies that govern not-for-profit academic institutions made a successful business model unattainable within university walls. Hence, in October 2019, the team formed a privately owned business.
Though initially heavily focused on microbial sequencing, SeqCenter evolved to meet the growing demand of customers and the market. With a move to a new 10,000-square-foot facility and installation of all of the highest throughput sequencing instruments (NovaSeqX, Revio, PromethION), SeqCenter now offers sequencing services to a global customer base and is able to provide services for any organism and from most sample types.
Despite our growth, we still hold true to our original aims: